Matt is a manager in ZS’s Philadelphia office and a member of the ZS oncology vertical leadership team. He has been with ZS for five years, supporting and leading oncology engagements in marketing strategy, market research, forecasting and secondary data analytics.

 

 

Matt’s expertise spans solid tumors and hematological malignancies, with a special interest in rare and difficult-to-treat tumor types. Matt has attended ASCO and ASH on behalf of the ZS oncology vertical for the past five years. In addition to advising his clients on the development and commercialization of novel oncology therapeutics.

 

 

Prior to focusing exclusively on oncology, Matt worked in data analytics and forecasting across therapeutic areas (including oncology). Before ZS, Matt worked with a boutique healthcare consulting firm, focused primarily in the CV and oncology spaces. Prior to consulting, he studied the impact of diet on the biophysics of neutrophil cell membranes.

 

 

Matt holds a Ph.D. in bioengineering from the University of Pennsylvania. He also holds a BSE in biomedical engineering from Duke University.